Skip to main content
Equibles

HighTower Advisors, LLC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1462245 CHICAGO, IL
Back to INO Full portfolio

Position in INO

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$14,003
-$6,701 QoQ
Shares Held
12,730
+7.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 101 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. INO ranks #110 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INBX
Inhibrx Biosciences, Inc.
 870,551 $82,484,707
2 REGN
Regeneron Pharmaceuticals, Inc.
 64,650 $40,311,861
3 ALNY
Alnylam Pharmaceuticals, Inc.
 105,045 $31,621,696
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 49,020 $24,349,704
5 RPRX
Royalty Pharma plc
 285,630 $16,015,274
6 EXEL
Exelixis, Inc.
 291,162 $15,842,124
7 AXSM
Axsome Therapeutics, Inc.
 56,313 $13,783,733
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 140,394 $11,443,514

All Filings in INO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,003 12,730
2026-03-31 $20,704 11,899
2025-12-31 $19,399 11,149
2024-03-31 $415,261 29,918
2023-09-30 $13,424 34,423
2023-06-30 $19,488 43,307
2023-03-31 $35,332 43,089
2022-12-31 $52,907 33,915
2022-09-30 $61,024 35,274
2022-06-30 $61,022 35,273
2022-03-31 $128,784 35,873
2021-12-31 $183,901 36,854
2021-09-30 $263,989 36,870
2021-06-30 $334,183 36,050
2021-03-31 $330,999 35,668
2020-12-31 $311,059 35,148
2020-09-30 $400,199 34,500
2020-06-30 $1,280,394 47,510
2020-03-31 $315,515 42,408